Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Animal pharmacokinetics and metabolism of OSU-6162 characterized

Nov. 29, 1999

Piracetam approved in Japan for cortical myoclonus Rx

Nov. 29, 1999

Sanofi-Synthelabo pipeline includes compounds with neurotrophic/neuroprotective effects

Nov. 26, 1999

Calcium channel blockers with piperidine structure synthesized at NeuroSearch

Nov. 26, 1999

Pozen licenses migraine prophylactic from Roche

Nov. 26, 1999

Abbott acquires anesthesia/analgesia products from Glaxo Wellcome

Nov. 26, 1999

Gliatech soon to begin phase II Perceptin trials in ADHD

Nov. 26, 1999

Pharmacokinetics of extended-release fampridine in MS patients discussed at AAPS meeting

Nov. 25, 1999

5-HT reuptake inhibitors in development at AHP for depression and other CNS disorders

Nov. 25, 1999

New paroxetine salts as alternatives to HCl

Nov. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...